A Closer Lab-Patient Connection
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Patient access to data from the clinical lab is increasing. What does this mean for those generating it?
New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.
On March 27, the agency released a new guidance document to help test developers make the transition to full approval.
The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.
Leanne Davey of Waters Corporation discusses recent technological trends in the clinical space with G2 managing editor Rachel Muenz.
A recent study provides insights on how to use automation and only 20 μL of a serum sample to quantify blood levels of antidepressants.
G2 Intelligence managing editor Rachel Muenz chats with lab leader Stephanie Whitehead about recent developments affecting clinical labs.
In the period from Mid-February through mid-March, three different products received first-of-their-kind clearances from the agency.
New technologies show potential for far greater accuracy and the ability to customize treatment options to improve outcomes.
The personalized test is designed to help inform post-surgery adjuvant therapies in CRC patients.
Principal investigator discusses a new research initiative to create a low-cost, rapid HIV self-test.